Toth Gabor, Tsukuda Mamoru
Dept. of Biology and Function in the Head and Neck, Graduate School of Medicine, Yokohama City University.
Gan To Kagaku Ryoho. 2004 Mar;31(3):461-7.
Quality of life (QOL) is a generic principle applicable to all people with or without disabilities. The measurement of QOL has grown to become a standard endpoint in many randomised controlled trials (RCT) and other clinical studies. QOL is recognised as an important factor in assessing treatment outcome. The aim of this article is to present useful information for evaluating the situations of people with head and neck cancer. We introduce the EORTC's cancer specific core questionnaire (QLQ-C30 version 3.0) together with the specific QLQ-H&N35 module for the QOL measurement of Japanese patients with head and neck cancer, which has been forward-backward translated into Japanese and undergone a coordinated Pilot-test and cross-cultural adaptation. It has been accepted by the EORTC Quality of Life Group as a Japanese version of the QLQ-H&N35 module.
生活质量（QOL）是一项适用于所有人群（无论是否残疾）的通用原则。生活质量的测量已发展成为许多随机对照试验（RCT）和其他临床研究中的标准终点。生活质量被认为是评估治疗结果的一个重要因素。本文的目的是提供有用信息，以评估头颈癌患者的状况。我们介绍了欧洲癌症研究与治疗组织（EORTC）的癌症特异性核心问卷（QLQ-C30第3.0版）以及用于日本头颈癌患者生活质量测量的特定QLQ-H&N35模块，该模块已进行了前后向翻译并被翻译成日语，并经过了协调的预试验和跨文化调适。它已被EORTC生活质量小组接受为QLQ-H&N35模块的日语版本。
